Treatment for Raynaud's: beyond calcium channel blockers.
Bergstrom
Kendra Gail
KG
Perelman
Ronald O
RO
D001120:Arginine / Q000008:administration & dosage; D000077300:Bosentan; D001905:Botulinum Toxins / Q000627:therapeutic use; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use; D011224:Prazosin / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D011928:Raynaud Disease / Q000188:drug therapy*; D000068677:Sildenafil Citrate; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use
D002121:Calcium Channel Blockers; D010879:Piperazines; D011687:Purines; D013449:Sulfonamides; D013450:Sulfones; D001120:Arginine; D000068677:Sildenafil Citrate; D001905:Botulinum Toxins; D000077300:Bosentan; D011224:Prazosin